Comparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database

Journal of Neurosurgery

Volumn 105, Issue 1, 2006, Pages 6-14

  Julià Sapé, Margarida ^b   Acosta, Dionisio ^b   Majós, Carles ^b   Moreno Torres, Àngel ^b   Wesseling, Pieter ^b   Acebes, Juan José ^b   Griffiths, John R ^b   Arús, Carles ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE

Author keywords

Brain tumor; Magnetic resonance imaging; Ontology; Predictive value; Sensitivity; Specificity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; CHILD; COLOR VISION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEUROEPITHELIOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR CELL; TUMOR CLASSIFICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, NERVE TISSUE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33745523113     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.105.1.6     Document Type: Article

References (23)

1. Altman DG: Diagnostic tests, in Altman DG, Machin D, Bryant TN, Gardner MJ (eds): Statistics with Confidence. Confidence Intervals and Statistical Guidelines, ed 2. Bristol, UK: BMJ Books, 2001, pp 105-119
2. Arle JE, Morriss C, Wang ZJ, Zimmerman RA, Phillips PG, Sutton LN: Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks. J Neurosurg 86:755-761, 1997
3. Bell A, Clinical Data Validation Committee: International Network for Pattern Recognition of Tumours Using Magnetic Resonance.INTERPRET consortium, IST-1999-10310, 2001. (http://azizu.uab.es/INTERPRET/clinical_data/ clinical_data.html) [Accessed 15 February 2005]
4. Bell D, Grant R, Collie D, Walker M, Whittle IR: How well do radiologists diagnose intracerebral tumor histology on CT? Findings from a prospective multicentre study. Br J Neurosurg 16:573-577, 2002
5. Burger PC, Kleihues P: Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 63:2014-2023, 1989
6. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381-1393, 1997
7. Favre J, Taha JM, Burchiel KJ: An analysis of the respective risks of hematoma formation in 361 consecutive morphological and functional stereotactic procedures. Neurosurgery 50:48-57, 2002
8. Field M, Witham TF, Flickinger JC, Kondziolka D, Lunsford LD: Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 94:545-551, 2001
9. Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, et al: Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60:248-262, 2001
10. Ginsberg LE, Fuller GN, Hashmi M, Leeds N, Schomer DF: The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49:436-440, 1998
11. Hagen T, Nieder C, Moringlane JR, Feiden W, König J: [Correlation of preoperative neuroradiological diagnosis with postoperative histological diagnosis in pathological intracranial processes.] Radiologe 35:808-815, 1995 (Ger)
12. Hall WA: The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 82:1749-1755, 1998
13. INTERPRET Consortium: Welcome to the INTERPRET Project (IST-1999-10310) Funded by the European Commission, 1999. (http://azizu.uab.es/INTERPRET) [Accessed 5 May 2006]
14. INTERPRET Consortium, IST-1999-10310: Guided Tour of the INTERPRET-Validated DB, 1999. (http://azizu.uab.es/INTER PRET/int_Disc_FrozenDB. shtml) [Accessed 5 May 2006]
15. Kleihues P, Cavenee WK: Pathology and Genetics of Tumours of the Nervous System, ed 2. Lyon: IARC Press, 2000
16. Kondziolka D, Lunsford LD, Martínez AJ: Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533-536, 1993
17. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al: Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989-1998, 2003
18. Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, et al: Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381, 2002
19. Murphy M, Loosemore A, Clifton AG, Howe FA, Tate AR, Cudlip SA, et al: The contribution of proton magnetic resonance spectroscopy (1HMRS) to clinical brain tumor diagnosis. Br J Neurosurg 16:329-334, 2002
20. Murphy M, Loosemore A, Ferrer I, Wesseling P, Wilkins PR, Bell BA: Neuropathological diagnostic accuracy. Br J Neurosurg 16:461-464, 2002
21. Osborn AG (ed): Astrocytomas and other glial neoplasms, in Diagnostic Neuroradiology. St. Louis: Mosby, 1994, pp 529-578
22. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, et al: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323-325, 1996
23. Stevens R, Goble CA, Bechhofer S: Ontology-based knowledge representation for bioinformatics. Brief Bioinform 1:398-414, 2000